In both the JoMa1 cell line (Schulte et al., 2013) and non-genetically modified neural crest cells (Olsen et al., 2017), overexpression of MycN was proven sufficient to generate neuroblastoma upon transplantation in immune-deficient mice. The gene discussed is MYCN; the disease is neuroblastoma.